Suchergebnisse - "Raphael, Ari"

PubPharm (16)

1

Body composition measures as a determinant of Alpelisib related toxicity

enthalten in: ResearchSquare.com | 2024

von Shachar, E. | Raphael, A. | Katz, U. | +2

2

Body composition measures as a determinant of Alpelisib related toxicity

enthalten in: Breast cancer research and treatment | 2024

von Shachar, E. | Raphael, A. | Katz, U. | +2

3

High neutrophil-to-lymphocyte ratio as an early sign of cardiotoxicity in breast cancer patients treated with anthracycline

enthalten in: Clinical cardiology | 2023

von Baruch, R. | Zahler, D. | Zornitzki, L. | +9

4

Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment

enthalten in: Genes | 2022

von Raphael, A. | Salmon-Divon, M. | Epstein, J. | +3

5

Valvular Heart Disease following Anthracycline Therapy-Is It Time to Look beyond Ejection Fraction?

enthalten in: Life (Basel, Switzerland) | 2022

von Zahler, D. | Arnold, J. | Bar-On, T. | +7

6

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)

enthalten in: Journal of clinical medicine | 2022

von Raphael, A. | Dudnik, E. | Hershkovitz, D. | +10

7

GENOMIC PROFILING IN LUMINAL BREAST CANCER

enthalten in: Harefuah | 2022

von Raphael, A. | Sonnenblick, A.

8

The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2nd/3rd-Generation ALK Tyrosine Kinase Inhibitors (TKIs)

enthalten in: Frontiers in oncology | 2022

von Raphael, A. | Onn, A. | Holtzman, L. | +14

9

Oncologic patients' misconceptions may impede enrollment into clinical trials : a cross-sectional study

enthalten in: BMC medical research methodology | 2022

von Asher, N. | Raphael, A. | Wolf, I. | +2

10

Oncologic patients’ misconceptions may impede enrollment into clinical trials: a cross-sectional study

enthalten in: BMC medical research methodology | 2022

von Asher, N. | Raphael, A. | Wolf, I. | +2